26S Proteasome p42D Antibodies

Santa Cruz Biotechnology offers a broad range of 26S Proteasome p42D monoclonal antibodies for research in protein degradation and cellular regulation. 26S Proteasome p42D Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 26S Proteasome p42D plays a critical role in the ubiquitin-proteasome pathway, which is essential for maintaining cellular homeostasis by regulating protein turnover and degradation. 26S Proteasome p42D is involved in various cellular processes, including cell cycle regulation, apoptosis, and responses to oxidative stress. Understanding 26S Proteasome p42D function is crucial for elucidating mechanisms of disease and developing therapeutic strategies. Researchers worldwide rely on 26S Proteasome p42D monoclonal antibodies to advance their studies in cellular regulation and protein degradation pathways. Current investigations of 26S Proteasome p42D continue to reveal new insights into cellular processes and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for 26S Proteasome p42D support researchers in making meaningful contributions to scientific understanding of protein degradation and cellular regulation.